Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: Part 2: Endpoint definitions

European Heart Journal

Volumn 36, Issue 29, 2015, Pages 1878-1891

  Stone, Gregg W ^a,b   Adams, David H ^c   Abraham, William T ^d   Kappetein, Arie Pieter ^e   Généreux, Philippe ^a,b,f   Vranckx, Pascal ^g   Mehran, Roxana ^b,c   Kuck, Karl Heinz ^h   Leon, Martin B ^a,b   Piazza, Nicolo ⁱ   Head, Stuart J ^e   Filippatos, Gerasimos ^j   Vahanian, Alec S ^k  

^a Department of Medicine   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c MOUNT SINAI HEALTH SYSTEM   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f Hôpital du SacrCrossed D Sign Coeur de MontrCrossed D Signal   (Canada)

^g Hartcentrum Hasselt   (Belgium)

^h DEPARTMENT OF CARDIOLOGY   (Germany)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^k BICHAT HOSPITAL   (France)

more..

Author keywords

Heart failure; Mitral regurgitation; Mitral valve; Valve intervention; Valve surgery (or cardiac surgery)

Indexed keywords

ACUTE KIDNEY FAILURE; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL CLASSIFICATION; COMPARATIVE EFFECTIVENESS; DEVICE FAILURE; DEVICE SAFETY; ENDOCARDITIS; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEMOLYSIS; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PERICARDIAL EFFUSION; PRIORITY JOURNAL; REVIEW; TECHNICAL AID; TRANSCATHETER MITRAL VALVE REPAIR; TRANSIENT ISCHEMIC ATTACK; VASCULAR ACCESS; VASCULAR DISEASE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; BIOASSAY; CLINICAL TRIAL (TOPIC); CONSENSUS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MITRAL VALVE INSUFFICIENCY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; PROCEDURES; PROSTHESIS FAILURE; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; CONSENSUS; ENDPOINT DETERMINATION; HEART FAILURE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITALIZATION; HUMANS; MITRAL VALVE INSUFFICIENCY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; PROSTHESIS FAILURE; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

EID: 84939498613     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv333     Document Type: Review

References (61)

1. Stone GW, Vahanian AS, Adams DH et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the Mitral Valve Academic Research Consortium. J Am Coll Cardiol 2015;66:278-307.
2. Krucoff MW, Mehran R, van Es GA, Boam AB, Cutlip DE. The Academic Research Consortium governance charter. J Am Coll Cardiol Intv 2011;4:595-596.
3. Cutlip DE, Windecker S, Mehran R et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351.
4. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-269.
5. Kappetein AP, Head SJ, Genereux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60: 1438-1454.
6. Mehran R, Rao SV, Bhatt DL et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123:2736-2747.
7. Généreux P, Head SJ, Van Mieghem NM et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012; 59:2317-2326.
8. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127: e6-e245.
9. Blecker S, Paul M, Taksler G et al. Heart failure-associated hospitalizations in the United States. J Am Coll Cardiol 2013;61:1259-1267.
10. Fonarow GC, Adams KF Jr., Abraham WT et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-580.
11. Jong P, Vowinckel E, Liu PP et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002; 162:1689-1694.
12. Alla F, Zannad F, Filippatos G. Epidemiology of acute heart failure syndromes. Heart Fail Rev 2007;12:91-95.
13. Tavazzi L, Maggioni AP, Lucci D et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006;27:1207-1215.
14. Ross JS, Chen J, Lin Z et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010;3:97-103.
15. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-1428.
16. Hauptman PJ, Schwartz PJ, Gold MR et al. Rationale and study design of the INcrease Of Vagal TonE in Heart Failure study: INOVATE-HF. Am Heart J 2012; 163:954-62.e1.
17. Bourge RC, Abraham WT, Adamson PB et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008;51:1073-1079.
18. Ruel M, Masters RG, Rubens FD et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg 2004;78:77-83.
19. Sacco RL, Kasner SE, Broderick JP et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:2064-2089.
20. Messe SR, Acker MA, Kasner SE et al. Stroke after aortic valve surgery: results from a prospective cohort. Circulation 2014;129:2253-2261.
21. Adams DH, Popma JJ, Reardon MJ et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-1798.
22. Philip F, Athappan G, Tuzcu EM et al. Mitra-Clip for severe symptomatic mitral regurgitation in patients at high surgical risk: a comprehensive systematic review. Catheter Cardiovasc Interv 2014;84:581-590.
23. Feldman T, Foster E, Glower DD et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-1406.
24. Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. Stroke 2008;39:1621-1628.
25. Lyden PD, Lau GT. A critical appraisal of stroke evaluation and rating scales. Stroke 1991;22:1345-1352.
26. Russo A, Grigioni F, Avierinos JF et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol 2008;51:1203-1211.
27. Lietz K, Brown K, Ali SS et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg 2009;137:1012-1019.
28. Spaziano M, Francese DP, Leon MB et al. Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. J Am Coll Cardiol 2014;64:1950-1963.
29. Floyd TF, Shah PN, Price CC et al. Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg 2006;81:2160-2166.
30. Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010;121:870-878.
31. Ghanem A, Muller A, Nahle CP et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010;55:1427-1432.
32. Knipp SC, Matatko N, Schlamann M et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005;28:88-96.
33. Cook DJ, Huston J 3rd, Trenerry MR et al. Postcardiac surgical cognitive impairment in the aged using diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2007;83:1389-1395.
34. Barber PA, Hach S, Tippett LJ et al. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke 2008;39:1427-1433.
35. Knipp SC, Matatko N, Wilhelm H et al. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2008;85:872-879.
36. Acker MA, Parides MK, Perrault LP et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370:23-32.
37. Maisano F, Franzen O, Baldus S et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 2013;62:1052-1061.
38. SchillingerW, Hunlich M, Baldus S et al. Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. Eurointervention 2013;9:84-90.
39. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-2035.
40. Novack V, Pencina M, Cohen DJ et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med 2012;172:502-508.
41. Muthu V, Kozman H, Liu K et al. Cardiac troponins: bench to bedside interpretation in cardiac disease. Am J Med Sci 2014;347:331-337.
42. Venge P, Johnston N, Lindahl B et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54: 1165-1172.
43. Moussa ID, Klein LW, Shah B et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol 2013;62:1563-1570.
44. Généreux P, Webb JG, Svensson LG et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012;60:1043-1052.
45. Généreux P, Cohen DJ, Williams MR et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63:1100-1109.
46. Murphy GJ, Reeves BC, Rogers CA et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552.
47. Konigstein M, Ben-Assa E, Abramowitz Y et al. Usefulness of updated Valve Academic Research Consortium-2 criteria for acute kidney injury following transcatheter aortic valve implantation. Am J Cardiol 2013;112:1807-1811.
48. Brown JR, Kramer RS, Coca SG et al. Duration of acute kidney injury impacts longterm survival after cardiac surgery. Ann Thorac Surg 2010;90:1142-1148.
49. Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444-2453.
50. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
51. Hochreiter C, Niles N, Devereux RB et al. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 1986;73:900-912.
52. Kligfield P, Hochreiter C, Niles N et al. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. Am J Cardiol 1987; 60:397-399.
53. van Bommel RJ, Ajmone Marsan N, Delgado V et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation 2011;124:912-919.
54. Russo AM, Stainback RF, Bailey SR et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2013;61:1318-1368.
55. Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329.
56. Berdajs D, Schurr UP, Wagner A et al. Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty. Eur J Cardiothorac Surg 2008;34:55-61.
57. Meimoun P, Zeghdi R, D'Attelis N et al. Frequency, predictors, and consequences of atrioventricular block after mitral valve repair. Am J Cardiol 2002;89:1062-1066.
58. Grayburn PA, Foster E, Sangli C et al. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation 2013;128:1667-1674.
59. Lim DS, Reynolds MR, Feldman T et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64:182-192.
60. Sürder D, Pedrazzini G, Gaemperli O et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013;99:1034-1040.
61. Durack DT, Lukes AS, Bright DK et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.